22 Aug 2016 | 03:21 pm |
International law firm Pinsent Masons has advised Numis on a £75 million fundraising for University of Cambridge investor, Cambridge Innovation Capital (CIC).
The funds will be used to provide investment to CIC's portfolio of technology businesses developed by the University of Cambridge and the wider Cambridge cluster, Europe's largest technology hub.
CIC launched in 2013 to provide growth capital to local tech businesses providing long term capital to support the sustained growth of investee companies.
A team at Pinsent Masons was led by corporate partner Russell Booker, assisted by corporate associate James Kaye.
Commenting on the deal Booker said: "This fundraising will be transformational for CIC and for the businesses it invests in. There has been a significant increase of new tech-based investment opportunities signalling a healthy pipeline of opportunities for CIC. We are delighted to have played a significant role in ensuring this valuable work continues."
Multinational law firm Pinsent Masons has advised the Supervisory Board of Telefónica Deutschland on the delisting tender offer of Telefónica Local Services GmbH, a subsidiary of Telefónica, S.A.
Multinational law firm Pinsent Masons has appointed litigation partner Melanie Ryan to join its Global Investigations team in London.
Law firm Pinsent Masons MPillay has advised Swiss-based infrastructure investment manager SUSI Partners on its investment in Alba Renewables to build a renewable energy infrastructure business focused on The Philippines.
Law firm Pinsent Masons MPillay has advised Swiss-based infrastructure investment manager SUSI Partners on its investment in Alba Renewables to build a renewable energy infrastructure business focused on The Philippines.
Pinsent Masons has advised Bestinver Infra, FCR on the acquisition of the remaining shares in N6 (Concession) Holdings Limited and N6 (Operations) Ltd, with Japanese co-investor Daiwa Energy & Infrastructure Co. Ltd.
Multinational law firm Pinsent Masons has advised Sandoz on the acquisition of the remaining shares in Rowex Limited, a joint venture in Ireland between Sandoz and Rowa Pharmaceuticals.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]
